COVID-19 respiratory failure management

Öz

2 months after the detection of the first Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) case in Wuhan, China, the first case was detected in our country on March 10, 2020. While the number of cases is increasing day by day, intensive care units are filled with patients who suffer from respiratory failure due to COVID-19. COVID-19 pandemic causes ARDS and multiorgan failure, requiring mechanical ventilator and 3rd step intensive care follow-up. For this reason, although there is no known effective treatment specific for the disease, supportive treatment which is provided in intensive care units are affects on mortality rates. In this review, our aim is to draw attention to the issues that need to be considered in the intensive care follow-up of people diagnosed with COVID-19.

Anahtar Kelimeler

• COVİD-19
• respiratory failure
• intensive care unit

COVİD-19 ve Solunum Yetmezliği Yönetimi

Öz

Çin’in Wuhan şehrinde ilk Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virüsü tespit edildikten yaklaşık 2 ay sonra ülkemizde de 10 mart 2020 de ilk vaka tespit edilmiştir. Vaka sayıları gün geçtikçe artarken hastalığın şiddetine göre önce yataklı servislerde daha sonra da yoğun bakım ünitelerinde yoğunluk yaşanmıştır. COVİD-19 pandemisi ARDS ve multiorgan yetmezliklerine neden olarak hastalarda mekanik ventilatör ihtiyacı ve 3. basamak yoğun bakım takibi gerektirmektedir. Bu nedenle hastalığın bilinen etkin bir tedavisi olmamasına rağmen yoğun bakımlarda sağlanan destek tedavisi hem hastalığın gidişatına hem de mortalite üzerine etkili olmaktadır.

Anahtar Kelimeler

• COVİD-19
• Yoğun Bakım
• solunum yetmezliği

Kaynakça

1. 1. COVID-19 outbreak control, example of ministry of health of Turkey. Demirbilek Y, Pehlivantürk G, Özgüler ZÖ, Meşe EA. Turk J Med Sci, 50, (2020), 489-494
2. 2. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China [published online ahead of print, 2020 Mar 13]. JAMA Intern Med. 2020;180(7):1-11. doi:10.1001/jamainternmed.2020.0994.
3. 3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020.
4. 4. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020.
5. 5. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382(13):1199–207
6. 6. Tian S, Hu N, Lou J, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020;80(4):401-406. doi:10.1016/j.jinf.2020.02.018
7. 7. T.C. Sağlık Bakanlığı Covid 19 Rehberi 1 Haziran 2020. https://covid19bilgi.saglik.gov.tr/tr/covid-19-rehberi.html
8. 8. WHO: coronavirus disease 2019 (COVID-19) situation report – 23. Geneva, Switzerland: World Health Organization; 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200212-sitrep-20200223 ncov.pdf?sfvrsn= 20200241e20200219fb20200278 20200212 [accessed 20200213 February 20202020].

9. 9. Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Critical Care 2020;24(1):28. doi: 10.1186/s13054-020- 2738-5.
10. 10. Tobin MJ, Laghi F, Jubran A. Caution about early intubation and mechanical ventilation in COVID-19. Ann Intensive Care. 2020;10(1):78. Published 2020 Jun 9. doi:10.1186/s13613-020-00692-6.
11. 11. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E et al. ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. Journal of American Medical Association 2012;307(23):2526-2533. doi: 10.1001/jama.2012.5669.
12. 12. Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes?. Intensive Care Med. 2020;46(6):1099-1102. doi:10.1007/s00134-020-06033-2.
13. 13. Takhar A, Walker A, Tricklebank S, et al. Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic. Eur Arch Otorhinolaryngol. 2020;277(8):2173-2184. doi:10.1007/s00405-020-05993-x.